The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.
暂无分享,去创建一个
[1] S. Nelson,et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.
[2] C. Der. Faculty Opinions recommendation of COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. , 2010 .
[3] Damien Kee,et al. Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. , 2010, Cancer cell.
[4] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[5] D. Fingar,et al. ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)* , 2010, The Journal of Biological Chemistry.
[6] D. Sabatini,et al. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. , 2010, Molecular cell.
[7] K. Flaherty,et al. Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.
[8] Francesca Molinari,et al. Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. , 2010, The Journal of clinical investigation.
[9] Q. She,et al. 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. , 2010, Cancer cell.
[10] P. Houghton,et al. Protection from rapamycin-induced apoptosis by insulin-like growth factor-I is partially dependent on protein kinase C signaling. , 2010, Cancer research.
[11] J. Downward,et al. Rictor is a novel target of p70 S6 kinase-1 , 2010, Oncogene.
[12] M. Holz,et al. mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor α serine 167 phosphorylation , 2010, FEBS letters.
[13] Philippe P Roux,et al. mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling , 2009, Molecular and Cellular Biology.
[14] Robert E. Lewis,et al. KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. , 2009, Cell metabolism.
[15] Kathryn G. Foster,et al. Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser863 and Multisite Phosphorylation* , 2009, The Journal of Biological Chemistry.
[16] Roger J Daly,et al. Function, regulation and pathological roles of the Gab/DOS docking proteins , 2009, Cell Communication and Signaling.
[17] J. Asara,et al. Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1 , 2009, Molecular and Cellular Biology.
[18] Wei Zhou,et al. In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models , 2009, Clinical Cancer Research.
[19] T. Veenstra,et al. KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. , 2009, Molecular cell.
[20] D. Helfman,et al. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility , 2009, Proceedings of the National Academy of Sciences.
[21] S. Gygi,et al. p90 Ribosomal S6 Kinase and p70 Ribosomal S6 Kinase Link Phosphorylation of the Eukaryotic Chaperonin Containing TCP-1 to Growth Factor, Insulin, and Nutrient Signaling* , 2009, Journal of Biological Chemistry.
[22] D. Alessi,et al. New Insights into mTOR Signaling: mTORC2 and Beyond , 2009, Science Signaling.
[23] M. Okada,et al. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK–ERK pathway to late endosomes , 2009, The EMBO journal.
[24] Laura M. Heiser,et al. Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition. , 2009, Cancer research.
[25] J. Hershey,et al. AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B , 2009, Oncogene.
[26] Ralph Weissleder,et al. Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers , 2008, Nature Medicine.
[27] Yong-Yeon Cho,et al. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells , 2008, Breast Cancer Research.
[28] J. Blenis,et al. The RSK family of kinases: emerging roles in cellular signalling , 2008, Nature Reviews Molecular Cell Biology.
[29] D. Chuderland,et al. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. , 2008, Experimental cell research.
[30] P. Pandolfi,et al. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. , 2008, The Journal of clinical investigation.
[31] W. Gerald,et al. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. , 2008, The Journal of clinical investigation.
[32] D. Kwiatkowski,et al. mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. , 2008, Molecular cell.
[33] J. Blenis,et al. Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1 , 2008, Proceedings of the National Academy of Sciences.
[34] G. Robertson,et al. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. , 2008, Cancer research.
[35] S. Gygi,et al. Ran-Binding Protein 3 Phosphorylation Links the Ras and PI3-Kinase Pathways to Nucleocytoplasmic Transport. , 2023, Molecular cell.
[36] G. Mills,et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation , 2008, Nature Cell Biology.
[37] E. Rozengurt. Mitogenic signaling pathways induced by G protein‐coupled receptors , 2007, Journal of cellular physiology.
[38] D. Hardie,et al. Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR. , 2007, The Biochemical journal.
[39] Lewis C. Cantley,et al. AKT/PKB Signaling: Navigating Downstream , 2007, Cell.
[40] D. Morrison,et al. Integrating signals from RTKs to ERK/MAPK , 2007, Oncogene.
[41] O. Rath,et al. MAP kinase signalling pathways in cancer , 2007, Oncogene.
[42] J. Pouysségur,et al. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition , 2007, Oncogene.
[43] J. Blenis,et al. RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation* , 2007, Journal of Biological Chemistry.
[44] O. Meyuhas,et al. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. , 2006, Trends in biochemical sciences.
[45] A. Clerk,et al. Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes. , 2006, Cellular signalling.
[46] G. Wildey,et al. Evidence That Ser87 of BimEL Is Phosphorylated by Akt and Regulates BimEL Apoptotic Function* , 2006, Journal of Biological Chemistry.
[47] N. Sonenberg,et al. Akt-Mediated YB-1 Phosphorylation Activates Translation of Silent mRNA Species , 2006, Molecular and Cellular Biology.
[48] Steven P. Gygi,et al. mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.
[49] E. Greer,et al. FOXO transcription factors at the interface between longevity and tumor suppression , 2005, Oncogene.
[50] Neal Rosen,et al. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. , 2005, Cancer cell.
[51] Jun Qin,et al. Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin , 2005 .
[52] E. Yorida,et al. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells , 2005, Oncogene.
[53] Frederick Y. Wu,et al. Phosphorylation of p27Kip1 at Thr-157 Interferes with Its Association with Importin α during G1 and Prevents Nuclear Re-entry* , 2005, Journal of Biological Chemistry.
[54] Lewis C Cantley,et al. A rapid method for determining protein kinase phosphorylation specificity , 2004, Nature Methods.
[55] Steven P Gygi,et al. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[56] A. Sickmann,et al. Identification of major ERK-related phosphorylation sites in Gab1. , 2004, Biochemistry.
[57] James M. Roberts,et al. p27Kip1 modulates cell migration through the regulation of RhoA activation. , 2004, Genes & development.
[58] J. Blenis,et al. Ribosomal S6 Kinase (RSK) Regulates Phosphorylation of Filamin A on an Important Regulatory Site , 2004, Molecular and Cellular Biology.
[59] T. Tsuruo,et al. Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization* , 2003, Journal of Biological Chemistry.
[60] N. Dumaz,et al. Protein Kinase A Blocks Raf-1 Activity by Stimulating 14-3-3 Binding and Blocking Raf-1 Interaction with Ras* , 2003, Journal of Biological Chemistry.
[61] T. Stossel,et al. Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1 , 2002, Nature Cell Biology.
[62] Magnus Bosse,et al. Regulation of Raf-Akt Cross-talk , 2002, The Journal of Biological Chemistry.
[63] Takashi Tsuruo,et al. Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization* , 2002, The Journal of Biological Chemistry.
[64] P. Hawkins,et al. Activation of Phosphoinositide 3-Kinase γ by Ras , 2002, Current Biology.
[65] S. Kane,et al. A Method to Identify Serine Kinase Substrates , 2002, The Journal of Biological Chemistry.
[66] B. Neel,et al. Receptor-Specific Regulation of Phosphatidylinositol 3′-Kinase Activation by the Protein Tyrosine Phosphatase Shp2 , 2002, Molecular and Cellular Biology.
[67] L. Cantley,et al. ERK Negatively Regulates the Epidermal Growth Factor-mediated Interaction of Gab1 and the Phosphatidylinositol 3-Kinase* , 2002, The Journal of Biological Chemistry.
[68] W. Kolch,et al. Cyclic AMP-Dependent Kinase Regulates Raf-1 Kinase Mainly by Phosphorylation of Serine 259 , 2002, Molecular and Cellular Biology.
[69] C. Proud,et al. The Extracellular Signal-regulated Kinase Pathway Regulates the Phosphorylation of 4E-BP1 at Multiple Sites* , 2002, The Journal of Biological Chemistry.
[70] W. Kolch,et al. Regulation of Raf‐1 activation and signalling by dephosphorylation , 2002, The EMBO journal.
[71] J E Paciga,et al. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. , 2001, Cancer research.
[72] M. Mann,et al. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[73] Laurence H. Pearl,et al. Crystal Structure of Glycogen Synthase Kinase 3β Structural Basis for Phosphate-Primed Substrate Specificity and Autoinhibition , 2001, Cell.
[74] C Eng,et al. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. , 2001, Human molecular genetics.
[75] G. Mills,et al. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[76] F. McCormick,et al. Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling* , 2000, The Journal of Biological Chemistry.
[77] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[78] Y Taya,et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.
[79] T. Barber,et al. Negative regulation of the serine/threonine kinase B-Raf by Akt. , 2000, The Journal of biological chemistry.
[80] J. Blenis,et al. Rsk1 mediates a MEK–MAP kinase cell survival signal , 2000, Current Biology.
[81] H. Ruan,et al. p90RSK Blocks Bad-mediated Cell Death via a Protein Kinase C-dependent Pathway* , 1999, The Journal of Biological Chemistry.
[82] K. Moelling,et al. Phosphorylation and regulation of Raf by Akt (protein kinase B). , 1999, Science.
[83] P. Cohen,et al. Role of protein kinase B and the MAP kinase cascade in mediating the EGF‐dependent inhibition of glycogen synthase kinase 3 in Swiss 3T3 cells 1 , 1999 .
[84] S. R. Datta,et al. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. , 1999, Science.
[85] T. Hunter,et al. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[86] P. Cohen,et al. Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B* , 1999, The Journal of Biological Chemistry.
[87] K. Guan,et al. Negative Regulation of the Forkhead Transcription Factor FKHR by Akt* , 1999, The Journal of Biological Chemistry.
[88] Susan S. Taylor,et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. , 1999, Molecular cell.
[89] J. Blenis,et al. pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167 , 1998, Molecular and Cellular Biology.
[90] Zhou Songyang,et al. Determination of the Specific Substrate Sequence Motifs of Protein Kinase C Isozymes* , 1997, The Journal of Biological Chemistry.
[91] Elizabeth Yang,et al. Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.
[92] J. Blenis,et al. The 70 kDa S6 Kinase Complexes with and Is Activated by the Rho Family G Proteins Cdc42 and Rac1 , 1996, Cell.
[93] J. Woodgett,et al. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. , 1994, The Biochemical journal.
[94] Peter J. Parker,et al. The activation of phosphatidylinositol 3-kinase by Ras , 1994, Current Biology.
[95] Michael J. Fry,et al. Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.
[96] Andrius Kazlauskas,et al. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase , 1994, Nature.
[97] P. Cohen,et al. The α‐isoform of glycogen synthase kinase‐3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase‐activated protein kinase‐1 in vitro , 1994, FEBS letters.
[98] J. Woodgett,et al. Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. , 1992, The Journal of biological chemistry.
[99] L. Cantley,et al. Activation of phosphatidylinositol 3-kinase by insulin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[100] A. Whale,et al. Signalling to cancer cell invasion through PAK family kinases. , 2011, Frontiers in bioscience.
[101] D. Alessi,et al. The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.
[102] Jun Qin,et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. , 2005, Molecular cell.
[103] P. Hawkins,et al. Activation of phosphoinositide 3-kinase gamma by Ras. , 2002, Current biology : CB.